CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | Grogan Jane Head of Research | Option exercise | +695 | 4,753 | ||
| 2026-10-30 | Grogan Jane Head of Research | Shares withheld for taxes | −345 | $253.62 | $87K | 4,408 |
| 2026-10-30 | Grogan Jane Head of Research | Option exercise · Restricted Stock Unit | −695 | 0 | ||
| 2026-02-13 | Grogan Jane Head of Research | Grant or award · Restricted Stock Unit | +8,450 | 8,450 | ||
| 2026-02-06 | Grogan Jane Head of Research | Option exercise | +1,385 | 3,176 | ||
| 2026-02-06 | Grogan Jane Head of Research | Shares withheld for taxes | −407 | $201.18 | $82K | 2,769 |
| 2026-02-06 | Grogan Jane Head of Research | Option exercise | +1,873 | 4,642 | ||
| 2026-02-06 | Grogan Jane Head of Research | Shares withheld for taxes | −584 | $201.18 | $117K | 4,058 |
| 2026-02-06 | Grogan Jane Head of Research | Option exercise · Restricted Stock Unit | −1,385 | 1,385 | ||
| 2026-02-06 | Grogan Jane Head of Research | Option exercise · Restricted Stock Unit | −1,873 | 3,747 | ||
| 2025-10-31 | Grogan Jane Head of Research | Option exercise | +695 | 2,128 | ||
| 2025-10-31 | Grogan Jane Head of Research | Shares withheld for taxes | −337 | $154.27 | $52K | 1,791 |
| 2025-10-31 | Grogan Jane Head of Research | Option exercise · Restricted Stock Unit | −695 | 695 | ||
| 2025-02-07 | Grogan Jane Head of Research | Option exercise | +1,385 | 1,876 | ||
| 2025-02-07 | Grogan Jane Head of Research | Shares withheld for taxes | −443 | $141.35 | $63K | 1,433 |
| 2025-02-07 | Grogan Jane Head of Research | Option exercise · Restricted Stock Unit | −1,385 | 2,770 | ||
| 2025-02-06 | Grogan Jane Head of Research | Grant or award · Restricted Stock Unit | +5,620 | 5,620 | ||
| 2024-11-01 | Grogan Jane Head of Research | Option exercise | +695 | 695 | ||
| 2024-11-01 | Grogan Jane Head of Research | Shares withheld for taxes | −204 | $173.79 | $35K | 491 |
| 2024-11-01 | Grogan Jane Head of Research | Option exercise · Restricted Stock Unit | −695 | 1,390 |
Page 1 of 2 · 22 trades